Procarbazine as adjunctive therapy for treatment of dogs with presumptive antemortem diagnosis of granulomatous meningoencephalomyelitis: 21 cases (1998-2004)

Journal of Veterinary Internal Medicine

Volumn 21, Issue 1, 2007, Pages 100-106

  Coates, Joan R ^a,d   Barone, Georgina ^b   Dewey, Curtis W ^b,c,d   Vitale, Christina L ^a   Holloway Azene, Nicole M ^a   Sessions, John K ^d  

^a UNIVERSITY OF MISSOURI   (United States)

^b Long Island Veterinary Specialist ^*  (United States)

^c Cornell University ^*  (United States)

^d TEXAS A AND M UNIVERSITY   (United States)

Author keywords

Canine; Central nervous system; Granulomatous meningoencephalomyelitis; Inflammatory; Meningitis

Indexed keywords

ANTIINFLAMMATORY AGENT; ANTINEOPLASTIC AGENT; PREDNISONE; PROCARBAZINE;

ANIMAL; ANIMAL DISEASE; ARTICLE; CASE REPORT; DOG; DOG DISEASE; DRUG COMBINATION; MENINGOENCEPHALITIS; RETROSPECTIVE STUDY;

ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTINEOPLASTIC AGENTS; DOG DISEASES; DOGS; DRUG THERAPY, COMBINATION; MENINGOENCEPHALITIS; PREDNISONE; PROCARBAZINE; RETROSPECTIVE STUDIES;

ANIMALIA; CANIS FAMILIARIS;

EID: 33847024379     PISSN: 08916640     EISSN: None     Source Type: Journal    
DOI: 10.1892/0891-6640(2007)21[100:PAATFT]2.0.CO;2     Document Type: Article

References (53)

1. Braund KG, Vandevelde M, Walker TL, et al. Granulomatous meningoencephalomyelitis in six dogs. J Am Vet Med Assoc 1978;172:1195-1200.
2. Cordy DR. Canine granulomatous meningoencephalomyelitis. Vet Pathol 1979;16:325-333.
3. Fankhauser R, Fatzer R, Luginbühl H. Reticulosis of the central nervous system (CNS) in dogs. Adv Vet Sci Comp Med 1972;16:35-71.
4. Cuddon PA, Smith-Maxie L. Reticulosis of the central nervous system in the dog. Compend Contin Ed Pract Vet 1984;6:23-32.
5. Muñana KR, Luttgen PJ. Prognostic factors for dogs with granulomatous meningoencephalomyelitis: 42 cases (1982-1996). J Am Vet Med Assoc 1998;212:1902-1906.
6. Vandevelde M. Neurologic diseases of suspected infectious origin. In: Greene CE, ed. Infectious Diseases of the Dog and Cat. Philadelphia, PA: WB Saunders; 1998:530-539.
7. Schatzberg SJ, Haley NJ, Barr SC, et al. Polymerase chain reaction screening for DNA viruses in paraffin-embedded brains from dogs with necrotizing meningoencephalitis, necrotizing leukoencephalitis, and granulomatous meningoencephalitis. J Vet Intern Med 2005;19:553-559.
8. Vandevelde M, Fatzer R, Fankhauser R. Immunohistological studies on primary reticulosis of the canine brain. Vet Pathol 1981;18:577-588.
9. Kipar A, Baumgärtner W, Vogl C, et al. Immunohistochemical characterization of inflammatory cells in brains of dogs with granulomatous meningoencephalitis. Vet Pathol 1998;35:43-52.
10. Sorjonen DC. Clinical and histopathological features of granulomatous meningoencephalomyelitis in dogs. J Am Anim Hosp Assoc 1990;26:141-147.
11. Russo M. Primary reticulosis of the central nervous system in dogs. J Am Vet Med Assoc 1979;174:492-500.
12. Koestner A, Zeman W. Primary reticulosis of the central nervous system in dogs. Am J Vet Res 1962;23:381-393.
13. Cordy DR, Holliday TA. A necrotizing meningoencephalitis of pug dogs. Vet Pathol 1989;26:191-194.
14. Stalis IH, Chadwick B, Dayrell-Hart B, et al. Necrotizing meningoencephalitis of Maltese dogs. Vet Pathol 1995;32:230-235.
15. Tipold A, Fatzer R, Jaggy A, et al. Necrotizing encephalitis in Yorkshire terriers. J Small Anim Pract 1993;34:623-628.
16. Schatzberg SJ. An update on granulomatous meningoencephalitis, necrotizing meningoencephalitis and necrotizing leukoencephalitis. Proceedings of the 23rd American College of Veterinary Internal Medicine Forum 2005;351-353.
17. Braund KG. Granulomatous meningoencephalomyelitis. J Am Vet Med Assoc 1985;186:138-141.
18. Ryan K, Marks SL, Kerwin SC. Granlomatous menigoencephalomyelitis in dogs. Compend Contin Ed Pract Vet 2001;23: 644-650.
19. Sarfaty D, Carrillo JM, Greenlee PG. Differential diagnosis of granulomatous meningoencephalomyelitis, distemper, and suppurative meningoencephalitis in the dog. J Am Vet Med Assoc 1986;188:387-392.
20. Sorjonen DC. Myelitis and meningitis. Vet Clin North Am Small Anim Pract 1992;22:951-964.
21. Thomas WB. Canine meningitis. Veterinary Forum 1996;39-44.
22. Tipold A. Diagnosis of inflammatory and infectious diseases of the central nervous system in dogs: A retrospective study. J Vet Intern Med 1995;9:304-314.
23. Bailey CS, Higgins RJ. Characteristics of cerebrospinal fluid associated with canine granulomatous meningoencephalomyelitis: A retrospective study. J Am Vet Med Assoc 1986;188:418-421.
24. Speciale J, Van Winkle TJ, Steinberg SA, et al. Computed tomography in the diagnosis of focal granulomatous meningoencephalitis: Retrospective evaluation of three cases. J Am Anim Hosp Assoc 1992;28:327-332.
25. Plummer SB, Wheeler SJ, Thrall DE, et al. Computed tomography of primary inflammatory brain disorders in dogs and cats. Vet Radiol Ultrasound 1992;33:307-312.
26. Lobetti R, Pearson J. Magnetic resonance imaging in the diagnosis of focal granulomatous meningoencephalitis in two dogs. Vet Radiol Ultrasound 1996;37:424-427.
27. Adamo FP, O'Brien RT. Use of cyclosporine to treat granulomatous meningoencephalitis in three dogs. J Am Vet Med Assoc 2004;225:1211-1216.
28. Thomas JB, Eger C. Granulomatous meningoencephalomyelitis in 21 dogs. J Small Anim Pract 1989;30:287-293.
29. Behrend EN, Kemppainen RJ. Glucocorticoid therapy: Pharmacology, indications, and complications. Vet Clin North Am Small Anim Pract 1997;27:187-213.
30. Coates JR. Granulomatous meningoencephalomyelitis. Stand Care: Emerg Crit Care Med 2003;5:1-4.
31. Cuddon PA, Coates JR, Murray M. New treatments for granulomatous meningoencephalomyelitis in dogs. Proceedings of the 20th American College of Veterinary Internal Medicine Forum 2002;319-321.
32. Oliverio VT, Denham C, Devita VT, et al. Some pharmacologic properties of a new antitumor agent N-isopropyl-(2-methylhydrazino)-p-tolumide hydrochloride (NSC-77213). Cancer Chemother Rep 1964;42:1-7.
33. Erikson JM, Tweedie DJ, Ducore JM, et al. Cytotoxicity and DNA damage caused by the azoxy metabolites of procarbazine in L1210 tumor cells. Cancer Res 1989;49:127-133.
34. Kitchell BE. Anticancer drugs and protocols using traditional drugs. In: Bonagura JD, ed. Kirk's Current Veterinary Therapy XIII. Philadelphia, PA: WB Saunders; 2000:465-473.
35. De Vita VT, Serpick AA, Carbone PP. Combination chemotherapy in the treatment of advanced Hodgkin's disease. Ann Intern Med 1970;73:881-895.
36. Spivack SD. Procarbazine: Diagnosis and treatment 5 years later. Ann Intern Med 1974;81:795-800.
37. Yung WK, Albright RE, Olson J, et al. A phase II study of temozolomide vs procarbazine in patients with glioblastoma at first relapse. Brit J Cancer 2000;83:588-593.
38. Newton HB, Bromberg J, Junck L, et al. Comparison between BCNU and procarbazine chemotherapy for treatment of gliomas. J Neuro Oncol 1993;15:257-263.
39. Schold SC, Brent TP, von Hofe E, et al. O-6-alkylguanineDNA alkyltransferase and sensitivity to procarbazine in human brain-tumor xenografts. J Neurosurg 1989;70:573-577.
40. Dunn DL, Lubet RA, Prough RA. Oxidative metabolism of isopropyl-α-(2-methylhydrazino)-p-toluamide hydrochloride by rat liver microsomes. Cancer Res 1979;39:4555-4563.
41. Nuhsbaum MT, Powell CC, Gionfriddo JR, et al. Treatment of granulomatous meningoencephalomyelitis in a dog. Vet Ophthamol 2002;5:29-33.
42. Suzuki M, Uchida K, Morozumi M, et al. A comparative pathological study on canine necrotizing meningoencephalitis and granulomatous meningoencephalomyelitis. J Vet Med Sci 2003;65:1233-1239.
43. Jull BA, Merryman JI, Thomas WB, et al. Necrotizing encephalitis in a Yorkshire terrier. J Am Vet Med Assoc 1997;211:1005-1007.
44. Ducote JM, Johnson KE, Dewey CW, et al. Computed tomography of necrotizing meningoencephalitis in 3 Yorkshire terriers. Vet Radiol Ultrasound 1999;40:617-621.
45. Von Praun F, Matiasek K, Grevel V, et al. Magnetic resonance imaging and pathologic findings associated with necrotizing encephalitis in two Yorkshire terriers. Vet Radiol Ultrasound 2006;47:260-264.
46. Lotti D, Capucchio MT, Gaidolfi E, et al. Necrotizing encephalitis in a Yorkshire Terrier: Clinical, imaging, and pathologic findings. Vet Radiol Ultrasound 1999;40:622-626.
47. Neer TM, Breitschwerdt EB, Greene RT, et al. Consensus statement on ehrlichial disease of small animals from the infectious disease study group of the ACVIM. American College of Veterinary Internal Medicine. J Vet Intern Med 2002;16:309-315.
48. O'Connor TP, Hanscom JL, Hegarty BC, et al. Comparison of an indirect immunofluorescence assay, Western blot analysis, and a commercially available ELISA for detection of Ehrlichia canis antibodies in canine sera. Am J Vet Res 2006;67:206-210.
49. Maggi RG, Duncan AW, Breitschwerdt EB. Novel chemically modified liquid medium that will support the growth of seven bartonella species. J Clin Microbiol 2005;43:2651-2655.
50. Baffour R, Achanta K, Kaufman J, et al. Synergistic effect of basic fibroblast growth factor and methylprednisolone on neurological function after experimental spinal cord injury. J Neurosurg 1995;83:105-110.
51. Henry MC, Marlow M. Preclinical toxicologic study of procarbazine (NSC-77213). Cancer Chemother Rep 1973;1973:4-97.
52. Meyer ME. Neurotoxicity of chemotherapy agents. In: Perry MC, ed. The Chemotherapy Source Book. Philadelphia, PA: Lippincott Williams & Wilkins; 2001:504-514.
53. Friedman HS, Averbuch SD, Kurtzberg J. Nonclassic alkylating agents. In: Chabner BA, Longo DL, eds. Cancer Chemotherapy and Biotherapy: Principles and Practice. Philadelphia, PA: Lippincott Williams & Wilkins; 2001:415-446.